Coinbase Global, Inc. vs Tilray Brands Inc — how do they compare? Coinbase Global, Inc. trades at $179.39 (market cap $45.38B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Coinbase Global, Inc. is far larger — about 85.5× Tilray Brands Inc's market cap, and Coinbase Global, Inc. is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Coinbase Global, Inc. for 78 Days and Tilray Brands Inc for 31 Days on average.
| COIN | TLRY | |
|---|---|---|
Market Cap | $45.38B | $530.54M |
Volume | 11,013,940 | 9,099,075 |
Sector | Financials | Health |
52-Week High | $361.43 | $17.20 |
52-Week Low | $141.09 | $3.54 |
Typical Hold Time | 78 Days | 31 Days |
Enterprise Value | $43.03B | $684.46M |
Signals from Pluang's Aura AI — not financial advice
Coinbase Global (COIN) trades at $172.00, down 3.61% on the day, reflecting recent volatility amid mixed earnings results. The stock's technical picture shows a bearish moving average trend but oversold RSI readings, with key support at $170. Fundamentally, 2025 revenue grew to $7.18 billion with $1.26 billion net income, though 2026 projections indicate a potential net loss. Analyst sentiment remains predominantly bullish with a $212.36 consensus price target, supported by recent CFTC approval for derivatives expansion and deepened banking partnerships.
The outlook for COIN hinges on reversing 2026 earnings misses and leveraging regulatory approvals for derivatives and stablecoin partnerships. Investment opportunity exists if the company returns to profitability and capitalizes on institutional crypto adoption, but risks include sustained negative earnings, competitive pressures, and crypto market volatility. Wall Street's buy-rated consensus suggests confidence in long-term execution despite near-term headwinds.
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →